STOCK TITAN

Naturl Alt Intl SEC Filings

NAII NASDAQ

Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking how Natural Alternatives International (NAII) turns niche nutritional science into revenue requires more than skimming headlines. Investors often ask, “Where can I read Natural Alternatives International’s quarterly earnings report 10-Q filing?” or “Which executives are buying shares in Natural Alternatives International insider trading Form 4 transactions?” This page collects every NAII disclosure, giving you a single starting point for Form 4 insider transactions in real-time, material 8-K events, and that dense annual report 10-K.

Stock Titan’s AI reads each document the minute it appears on EDGAR, then delivers summaries, red-flag highlights, and plain-English answers—so understanding Natural Alternatives International SEC documents with AI takes minutes, not hours. Whether you need Natural Alternatives International earnings report filing analysis, a quick breakdown of segment margins hidden deep in the 10-Q, or Natural Alternatives International proxy statement executive compensation details, our platform surfaces the numbers and narratives that move the stock.

Because NAII operates as a contract manufacturer of custom nutritional supplements, its disclosures spotlight capacity utilization, raw-material sourcing, and patent licensing revenue. Our timeline highlights Natural Alternatives International 8-K material events explained in plain language, while the Natural Alternatives International executive stock transactions Form 4 can signal management’s view on inventory cycles. For long-term context, the Natural Alternatives International annual report 10-K simplified by our AI uncovers trends in private-label demand and R&D spending on proprietary blends. Bookmark this hub to monitor every Natural Alternatives International SEC filings explained simply—each document arrives in chronological order with AI-powered context, letting you move from data to decision quickly.

Rhea-AI Summary

Natural Alternatives International, Inc. (NASDAQ: NAII) filed an 8-K announcing the execution of a Sixth Amendment to its credit agreement with Wells Fargo, effective June 20, 2025.

Key terms

  • Maturity extended from the current expiry to December 31, 2026, giving NAII an additional 18 months of committed bank financing.
  • Revolving credit limit reduced from $12.5 million to $10 million, lowering undrawn liquidity head-room by $2.5 million.
  • Collateral expanded: the company’s Carlsbad, CA powder-processing facility is now pledged, and the existing Deed of Trust is modified to secure both the term loan and the amended revolver.
  • All other security agreements, including the July 1, 2019 Security Agreement, remain in force.

The amendment package consists of three executed documents (Exhibits 10.40-10.42) and is accompanied by a press release dated June 23, 2025 (Exhibit 99.9). No financial statements were included.

Management characterizes the change as a material definitive agreement (Item 1.01) and a direct financial obligation (Item 2.03). The filing provides no update on current borrowings, covenant levels or interest pricing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.1%
Tags
current report

FAQ

What is the current stock price of Naturl Alt Intl (NAII)?

The current stock price of Naturl Alt Intl (NAII) is $3.28 as of June 30, 2025.

What is the market cap of Naturl Alt Intl (NAII)?

The market cap of Naturl Alt Intl (NAII) is approximately 20.6M.

What is the primary business of Naturl Alt Intl (NAII)?

NAII specializes in formulating, manufacturing, and marketing customized nutritional supplements, serving clients through private-label contract manufacturing and patent & trademark licensing.

How does NAII ensure the quality of its products?

The company employs advanced quality assurance testing, state-of-the-art manufacturing technologies, and rigorous regulatory compliance protocols to ensure high-quality production standards.

What makes NAII's partnership model unique?

NAII offers an integrated, end-to-end approach—covering scientific research, formulation, clinical testing, manufacturing, packaging, and marketing support—tailored to each client's specific needs.

Which industries and market segments does NAII serve?

NAII caters to the nutritional and healthcare industries, providing customized solutions in vitamins, minerals, herbs, and other nutritional supplements to both domestic and international markets.

How does NAII maintain its competitive position in the market?

By combining scientific research with advanced manufacturing and a comprehensive service model, NAII differentiates itself from competitors that rely solely on off-the-shelf products.

What role does innovation play in NAII's operations?

Innovation is central to NAII's approach, as it continually integrates cutting-edge research and manufacturing technologies to develop proprietary formulations and advanced nutritional solutions.

How does NAII manage regulatory compliance for its products?

NAII maintains a strict focus on international regulatory standards and quality assurance practices, ensuring that every product undergoes detailed testing and meets all required safety protocols.

What are the main revenue streams for NAII?

NAII generates revenue primarily from private-label contract manufacturing services and from royalty income and licensing fees associated with its patented nutritional formulations.
Naturl Alt Intl

NASDAQ:NAII

NAII Rankings

NAII Stock Data

20.58M
4.86M
21.52%
34.36%
0.04%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
CARLSBAD